tommynockers trademark of equels thomas k serial number   trademarkia trademarks apply online attorneys services us trademark registration service international trademark registration service trademark office action response trademark statement of use trademark renewal trademark assignment trademark watch trademark cease  desist trademark comprehensive search copyright registration patent services incorporation services business page creation more services help contact us login trademark search trademark category clothing products tommynockers   get free email alerts tommynockers trademark information equels thomas k perfect for these industries clothing products words that describe this mark womens   clothing     shorts     shirts     slacks     pants   jeans   this is a brand page for the tommynockers trademark by equels thomas k  in miami   write a review about a product or service associated with this tommynockers trademark or contact the owner equels thomas k of the tommynockers trademark by filing a request to communicate with the legal correspondent for licensing use andor questions related to the tommynockers trademark on friday may   a us federal trademark registration was filed for tommynockers by equels thomas k miami  the uspto has given the tommynockers trademark serial number of  the current federal status of this trademark filing is abandoned  no statement of use filed the correspondent listed for tommynockers is l jana sigars of holtzman krinzman equels  furia  s bayshore drive suite  miami fl   the tommynockers trademark is filed in the category of clothing products  the description provided to the uspto for tommynockers is womens clothing namely shorts shirts slacks pants and jeans word mark tommynockers statusstatus date abandoned  no statement of use filed  serial number  filing date  registration number not available registration date not available goods and services womens clothing namely shorts shirts slacks pants and jeans mark description not available type of mark trademark published for opposition date  last applicantowner equels thomas kmiami  why is this contact information displayed why is this contact information displayed close the uspto makes this data available for search by the public so that individuals can locate ownership information for intellectual property much the same way a county might make real estate property ownership information available since our website is synchronized with the uspto data we recommend making any data changes with the uspto directly our website will autoupdate when the uspto data is updated you may also contact trademarkia to make a request for the removal of your personally identifiable information or trademark data such requests must be made in writing and will be subject to verification of ownership this policy allows verified trademark owners to specify a that their identifiable information be masked or b that their trademark pages permanently deleted from trademarkiacom requests may be made directly to customerservicetrademarkiacom and every effort will be made to honor them within  hours click here for further details close mark drawing code typeset wordsletternumber design search no data register type principal disclaimer not available correspondent l jana sigars holtzman krinzman equels  furia  s bayshore drive suite  miami fl  intent to use trademark  applicant has not submitted proof of use in commerce the the uspto classification information primary class class   clothing footwear headgear first use anywhere not provided first use in commerce not provided trademarkia is the largest search engine for us trademarks each month hundreds of trademarks around the world are filed by licensed attorneys in the legalforcetrademarkia network you can register your trademark in  countries in the world through legalforce network legalforce network can help you incorporate a business around your tommynockers trademark in less than  minutes trademarkia makes the process easy and convenient so start now trademarkiacom is a free search engine of publicly available government records trademarkiacom is not a law firm and does not represent owners  correspondents listed on this page trademark document retrieval  trademark  apply online  satisfaction guarantee protect your valuable brand now how it works what you get  legalforce rapc   us trademark filing from  to now  describe how your business or product is being used register your mark in  countries just   govt fees start here   top global ip attorneys  credibility and experience  all processes will be performed in a timely manner you will be informed periodically about the process keep track of this brand trademark watch services keep track of how your trademark is being used available in the united states and in more than  countries roundtheclock monitoring monthly report on potential infringement watch this trademark trademark watch services read more current trademark status  abandoned  no statement of use filed free trademark search correspondent search l jana sigars is a correspondent of tommynockers trademark current overall rating  review what you can do start your business free logo creator add to favorites view documents free trademark search start trademark filing process protect this mark internationally custom logo design  search tommynockers on popular social networks trademarkia lets you see how your personal name product name trademark name or username is being used on any of  new and popular social networks be the first to reserve your name and get help stopping others from using it  all in one place trademark oppose service you can request for extension of time to oppose this mark or oppose it now  if you are new to legalforcetrademarkia please just enter your contact email and create a password  if you already have a legalforcetrademarkia account please enter your accounts email and password  email address please enter your email address  enter password please enter your password  please enter the value       status update alerts status update alerts are email updates of the latest trademark status change please make sure you provide the correct email  if you are new to legalforcetrademarkia please just enter your contact email and create a password  if you already have a legalforcetrademarkia account please enter your accounts email and password  email address please enter your email address  enter password please enter your password  please enter the value       review  rating please rate and review for tommynockers tommynockers is providing womens clothing namely shorts shirts slacks pants and jeans  if you are new to legalforcetrademarkia please just enter your contact email and create a password to be associated with your review if you already have a legalforcetrademarkia account please enter your accounts email and password before posting your review  please rate        your review please enter your review  email address please enter your email address  enter password please enter your password       thomas equels hemispherx biopharma inc profile  biography  bloomberg feedback thomas equels vice chairmanpresceosecy hemispherx biopharma inc career history vice chairmanpresceosecy hemispherx biopharma inc present presidentmanaging director equels law firm present vice chairmanpressecygen cnsl hemispherx biopharma inc  vice chairmancfosecygen cnsl hemispherx biopharma inc  vice chairmansecygen cnsl hemispherx biopharma inc  secygen cnsl hemispherx biopharma inc  secycogen cnsl hemispherx biopharma inc  secretary hemispherx biopharma inc  litigation lawyer hemispherx biopharma inc unknown counsel republic of panama former counsel chinese natl petroleum corp former managing director holtzman equels pa former show more website wwwhemispherxnet corporate information address  jfk boulevard suite  philadelphia pa  united states phone  fax  web url wwwhemispherxnet from the web personal information education florida state university jd troy university bachelors degree troy university masters degree show more memberships board memberships hemispherx biopharma inc vice chairman present hemispherx biopharma inc board member  other memberships florida bar association member american bar association member academy of florida trial lawyers member show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data hemispherx biopharma inc home  careers  contact us investor relations investor relations press releases events  presentations stock information sec filings annual stockholder meeting corporate governance email alerts investor contacts  partnering  r  d product candidates overview pipeline orphan drug designations  products  company overview manufacturing  research facility management board of directors careers overviewmanufacturing  research facilitymanagementboard of directorscareers management thomas k equels ms jd executive vice chairman chief executive officer president thomas k equels ms jd was named chief executive officer in february  served as president since august  has been a director since  and presently serves as our executive vice chairman mr equels previously served as secretary from  to  general counsel from  to  and chief financial officer from december  to february  while serving fulltime at hemispherx mr equels has been the president and managing director of the equels law firm based in miami florida that focuses on litigation for over a quarter century mr equels has represented national and state governments as well as companies in the banking insurance aviation pharmaceutical and construction industries on numerous occasions mr equels has been the court appointed receiver to turnaround distressed companies mr equels received his juris doctor degree with high honors from florida state university he is a summa cum laude graduate of troy university and also obtained his masters degree in management from troy he is a member of the florida bar association and the american bar association adam pascale cpa chief financial officer adam pascale was named chief financial officer in february  in addition to his current responsibilities as chief accounting officer mr pascale has been employed with hemispherx since  with more than two decades of public accounting experience and prior public company experience he earned a bachelor of arts ba degree in accounting and finance from rutgers university mr pascale served for several years as a cpa prior to joining hemispherx and is a member of both the american and the pennsylvania institutes of certified public accountants david r strayer md  chief scientific  medical officer david r strayer md was appointed chief scientific officer in feburary  and has acted served as our medical director since  dr strayer based upon this experience is the foremost medical expert on ampligen and alferon in the world he has served as professor of medicine at the medical college of pennsylvania and hahnemann university from  to  dr strayer is board certified in medical oncology and internal medicine with research interests in the fields of cancer and immune system disorders he has served as principal investigator in studies funded by the leukemia society of america the american cancer society and the national institutes of health dr strayer attended the school of medicine at the university of california at los angeles where he received his md in    peter w rodino iii esq executive director for governmental relations general counsel secretary peter w rodino iii esq was named executive director for governmental relations and general counsel in october  and secretary of the company in november  mr rodino was appointed a director of the company in july  and served in that capacity until his resignation to permit him to serve the company in this new capacity while on the board he served as lead director chairman and financial expert of the audit committee a member of the compensation committee and a member of the governance and nomination committeeappointed lead director in september  and has served as a member of to the board of directors since july  mr rodino has broad legal financial and executive experience in addition to being president of rodino consulting llc and managing partner at several law firms during his many years as a practicing attorney he served as chairman and ceo of crossroads health plan the first major health maintenance organization in new jersey he also has had experience as an investment executive in the securities industry and acted as trustee in numerous chapter  complex corporate reorganizations for the past  years as founder and president of rodino consulting mr rodino has provided business and government relations consulting services to smaller companies with a focus on helping them develop business plans implement marketing strategies and acquire investment capital mr rodino holds a bs in business administration from georgetown university and a jd degree from seton hall university wayne springate  senior vice president of operations wayne s springate has served as senior vice president of operations since may  after joining hemispherx in  as vice president of business development mr springate came on board when hemispherx acquired alferon n injection® and its new brunswick nj manufacturing facility he led the consolidation of our rockville facility to our new brunswick location as well as coordinated the relocation of manufacturing polymers from south africa to our production facility in new brunswick currently he is managing a capital improvement budget to enhance our alferon® facility in accordance with current good manufacturing practice “cgmp” previously mr springate served as president for world fashion concepts in new york and oversaw operations at several locations throughout the united states and overseas mr springate assists the ceo in details of operations on a daily basis and is involved in all aspects of manufacturing warehouse management distribution and logistics site map  privacy  terms of use copyright   hemispherx biopharma inc  all rights reserved bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vz log in for events urbn urbn syna ll hp log in for events alks cvrr cvrr esnd find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  form  hemispherx biopharma for jun  filed by equels thomas k research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  hemispherx biopharma for jun  filed by equels thomas k by k wizard—  am et  httparchivefastedgarcomauaczizudoubym filed on june   more heb news briefhemispherx says promotion of carol smith as chief manufacturing officer deputy chief scientific officer reuters   pm et  briefhemispherx biopharma announces quarterly loss per share  reuters   pm et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  thomas k equels pa credit report products contacts florida search thomas k equels pa company number p status active fei number  company type domestic for profit home state fl last activity date not available date of incorporation  principal address  ponce de leon blvd coral gables fl  mailing address  ponce de leon blvd coral gables fl  thomas k equels pa fictitious names active equels law active equels law firm thomas k equels pa principals president director equels thomas kesq address  s bayshore dr ste  miami fl  vice president president director fabar laura m address  s bayshore dr ste  miami fl  director orrick judson h address  east jefferson street tallahassee fl  last annual reports       registered agent agent name equels thomas kesq p agent address  ponce de leon boulevard miami fl  description thomas k equels pa has been set up  in state fl the current status of the business is active the thomas k equels pa principal adress is  ponce de leon blvd coral gables fl  meanwhile you can send your letters to  ponce de leon blvd coral gables fl  the companys registered agent is equels thomas kesq  ponce de leon boulevard miami fl  the companys management are president director  equels thomas kesq vice president president director  fabar laura m director  orrick judson h the company annual reports filed on annual reports –  comprehensive report about this company view sample similar companies thomas kern electric inc thomas kershaw flooring llc thomas kevin mehring pa thomas k farley pa thomas k flanigan od  associates pa thomas k goldie inc thomas k equels profile  equels law firm  attorneys at law  florida litigation personal injury and family law equels law firm   ponce de leon blvd suite coral gables fl  more locations firm profile practice areas resources the attorneys contact us home page thomas k equels   tom equels is the president and managing director of the equels law firm his practice is devoted to complex litigation with particular emphasis on civil racketeering business torts and commercial matters for more than  years tom has represented national and state governments and companies in the banking insurance aviation pharmaceutical construction and development industries he has extensive experience in international matters and has served as counsel for the republic of panama and chinese national petroleum corp he has worked extensively in europe as well as in south america asia and africa mr equels currently serves as cfo general counsel and a director of the board of hemispherx biopharma inc nyse mktheb mr equels received his law degree with high honors from florida state university and is a graduate summa cum laude of troy state university   career achievements obtained a  million judgment in  on behalf of his client hemispherx biopharma inc amex heb against johannesburg consolidated investments jci and former jci officers rb kebble and hc buitendag the judgment entered august   marks the conclusion of the federal lawsuit first filed in late  against jci et al obtained a  million judgment in  in a breach of contract action against bear stearns for the delaware insurance commissioner related to an insolvent insurance company obtained a  million judgment in  against boy band guru lou pearlman of trans continental records inc obtained a  million judgment against manuel noriega for public money he misappropriated from the republic of panama recovered more than  million misappropriated and money laundered overseas by former insiders of a nowdefunct insurance company being liquidated by the state of delaware’s insurance commissioner obtained and collected a  million judgment against the fdic for breach of contract involving a client’s purchase of a national mortgage company owned by a failed savings and loan prosecuted a bank fraud claim against an international lender which resulted in a jury awarding  million damages for fraud and an order invalidating a  million mortgage obtained a jury verdict and recovered over  million in an eminent domain case in which the department of transportation was offering only    academic achievements received juris doctor with high honors florida state university college of law  member of the order of the coif received bachelor’s degree summa cum laude troy state university  received master’s degree in management troy state university    professional and community involvement honored with two distinguished flying crosses the bronze star  air medals  with “v” device and the purple heart for combat actions as a pilot during the vietnam war awarded the florida bar president’s pro bono service award  awarded the federal bar public service award  awarded the guild of catholic lawyers st thomas more award  received the southern christian leadership conference of miami’s dr martin luther king jr community service award  member florida bar member american bar association member academy of florida trial lawyers   references catherine mulholland deputy commissioner of insurance state of delaware retired  harlech drive wilmington delaware   kmulhollandcomcastnet   daniel a orth iii executive director illinois life  health insurance guaranty association  w bryn mawr avenue suite  chicago illinois   dorthilhigaorg   archbishop thomas g wenski the archdiocese of miami  biscayne blvd miami shores fl   comments are closed home firm profile practice areas the attorneys resources contact us  equels law firm all rights reserved new ceo defers pay until stock improves  philadelphia business journal menu select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita limited time offer subscribe now search × close sign in sign in your account your account welcome your account sign in existing users create your free account dont have an account your account subscriptions newsletters custom notifications my custom site manage site users sign out sign in sign in your account search home industries  topics all industries  topics banking  financial services career  workplace commercial real estate education energy food  lifestyle government  regulations health care manufacturing media  marketing philanthropy  nonprofits professional services residential real estate retailing sports business technology transportation travel  tourism sponsored content cre now we value your business office environments small business marketing know your neighborhood news news latest news business pulse press releases subscribers subscriberonly content digital edition start a subscription sign up for newsletters lists  awards lists all lists access the book of lists purchase the book of lists build your own lists submit your company to be on a list awards nominate for an award people  companies companies top private companies find businesses for sale search for company news people people on the move contact top executives executive profiles search for people in the news events events business event calendar nominations add your event event photos signature events bizwomen mentoring monday more… jobs find or post a job in philadelphia store subscriptions reprints  more sales leads public records information to build your business how to grow your business advance your career home of the day premium real estate listings in philadelphia bizspace best office spaces available in philadelphia thought leadership trends tips and insights from our partners local directories subscribers start a subscription subscriberonly content digital edition access the book of lists purchase the book of lists manage your account about  contact about us about the business journals advertise help  faqs contact us call center directory apps  syndication newsletters mobile apps syndicationrss acbj publications bizwomen upstart hemmings sports business journal inside lacrosse bostinno dcinno chicagoinno austininno select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita follow us twitter linkedin facebook google  please sign in and use this articles on page print button to print this article hemispherx biopharma new ceo defers pay until stock improves mar   am est industries  tags banking  financial services biotech john george senior reporter philadelphia business journal share order reprints save article print email facebook linkedin twitter save article more email facebook linkedin order reprints twitter save article john george senior reporter philadelphia business journal home of the day sponsor listing historically inspired new townhome  the jefferson see all homes of the day enlarge new hemispherx biopharma chairman dr william m mitchell with newly promoted ceo thomas… more john george hemispherx biopharma’s newly appointed ceo has agreed to defer  percent of his salary for a twomonth period and only get that money back if the company’s stock performance improves — to make a statement to the philadelphia biotechnology company’s investors “i want our stockholders to know when we say we have two priorities — increasing stockholder value and providing products to the patients who need them — it’s not just talk” said thomas k equels enlarge new hemispherx biopharma chairman dr william m mitchell with newly promoted ceo thomas… more john george hemispherx has long been attempting to develop ampligen for a variety of therapeutic uses including chronic fatigue syndrome and cancer and will now be seeking partners to help bring the drug to market it is also planning to resume production of alferon n a genital warts treatment once the fda approves the manufacturing of the drug at the company’s recently renovated plant in new brunswick nj equels a former army helicopter pilot worked as an attorney in a private practice before joining hemipsherx’s management team in  he had been serving as president when elevated to ceo last month after the company terminated the employment contract of dr william a carter the company’s former longtime chairman and ceo prior to the termination both carter and equels — the company’s two primary executives — had agreed in january to a “deferred cash performance award plan” that temporarily withholds  percent of their pay for a threemonth period beginning feb  that can be extended with board approval equels’ base salary was  in  according to sec documents data for  has not been filed by the company earlier this year ramesh kumar ceo of onconova therapeutics agreed to a voluntary reduction in his base salary from  to  as part of a cashconservation plan that included the newtown biopharmaceutical company eliminating the jobs of six of its  employees under the hemispherx deferred executive payment plan the salary withheld by equels will be paid only after the company’s stock price trades for at least  cents per share for five successive trading days after taking over as ceo equels decided to take a bolder step and defer  percent of his salary in march and april and at least  percent of his salary if the deferred payment plan is extended by the board the same stock price threshold must be met for his deferred salary to be paid the plan is also structured so if the company’s performance improves above the  cents per share target his deferred pay would be increased fractionally the stock opened this week  cents a share it hasn’t been above  cents since last summer and was as low as  cents a share last month “i thought about how i could best demonstrate the seriousness of my resolve and i was reminded of lee iacocco” equels said referring to the former chrysler ceo of who took a  a year salary and deferred bonus payments while leading the automobile maker through a financial crisis “i’ve taken this step so our stockholders can know i am not just talking… we are in a battle now not only to save this company but to save these products “i am now the leastpaid employee of hemispherx” equels said “hopefully nobody says you get what you paid for” john george covers health care biotechpharmaceuticals and sports business home of the day sponsor listing historically inspired new townhome  the jefferson see all homes of the day industries banking  financial services topics biotech suggested reading sponsor listing home of the day see all photos historically inspired new townhome  the jefferson see all homes of the day heb stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsheb hemispherx biopharma inc new    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all briefhemispherx biopharma updates status of immunooncology program in pancreatic cancer reuters –  am et  hemispherx biopharma inc heb  hemispherx updates status of immunooncology program in pancreatic cancer briefhemispherx says promotion of carol smith as chief manufacturing officer deputy chief scientific officer reuters –  pm et  hemispherx biopharma inc heb  hemispherx biopharma inc heb says promotion of carol smith as chief manufacturing officer and deputy chief scientific officer  hemispherx biopharma inc heb says smith will be responsible for all manufacturing processes of ampligen and alferon source text for eikon further company coverage briefhemispherx biopharma announces quarterly loss per share  reuters –  pm et  hemispherx biopharma inc heb  hemispherx biopharma heb announces financial results for the three months ended march    quarterly loss per share   hemispherx biopharma heb have begun to generate and can now reasonably project growing future revenues from newly manufactured lots of ampligen for  page page  todays and upcoming events aug  heb to announce q earnings after market unconfirmed sep  shareholders meeting past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe hemispherx biopharma board appoints new president nyseheb english français register sign in hemispherx biopharma board appoints new president seasoned executive with extensive international experience august    et  source hemispherx biopharma inc photorelease thomas k equels thomas k equels president of hemispherx biopharma philadelphia aug   globe newswire  hemispherx biopharma inc nyse mktheb the company or hemispherx today announced that the board has appointed thomas equels as the new president for hemispherx biopharma inc according to peter rodino chairman of the audit committee and an independent director on behalf of the independent directors we are pleased to announce equels expanded role in providing a strong new executive emphasis creating greater operational efficiencies through seeking to achieve significant operational savings he will also have a clear mandate from the board to strengthen internal controls achieve enhanced governance and create an environment for greater stockholder value this strengthened executive role we believe will far better serve our corporate goals a photo accompanying this release is available at httpwwwglobenewswirecomnewsroomprspkgid equels has served as executive vice chairman chief financial officer secretary and general counsel of hemispherx equels experience and education provide a firm basis for his executive service for more than thirty years his legal practice focused on complex business litigation including cases related to corporate finance and market issues for example in  he won floridas highly coveted most effective lawyer award in the complex business litigation category based upon obtaining for the delaware insurance commissioner a  million judgment against bear stearns in a case which unraveled bear stearns abuses related to cmos a complex financial instrument in a rare feat that same year he also was awarded most effective lawyer in the appellate category for a florida supreme court win in an important medical records access case with major constitutional implications equels also has extensive experience in international matters for example he has served for many years as international counsel for the republic of panama and also as litigation counsel for the peoples republic of chinas chinese national petroleum corp he has worked extensively in europe as well as in south america asia and africa equels received his juris doctor degree magna cum laude from florida state university and is a bachelor of science summa cum laude graduate of troy university where he also received a management related master of science degree equels has also demonstrated a strong commitment to civic duties he was awarded by order of the president of the united states two distinguished flying crosses for heroism in combat actions as a cobra gunship pilot during the vietnam war he has also received the bronze star  air medals  with v device for valor the purple heart and the rvn cross of gallantry for his combat services in vietnam as a lawyer he has been awarded the florida bar presidents pro bono service award the federal bar associations public service award the guild of catholic lawyers st thomas more award and the southern christian leadership conferences dr martin luther king jr community service award in  pope benedict xvi in one of the vatican states highest honors for a layperson made equels a papal knight in the chivalric order of st gregory the great this award of knighthood was in recognition of his many years of service to the poor and disenfranchised in his community dr william carter hemispherx chairman and ceo and chief science officer explains this is a logical progression of mr equels extraordinary achievements across a wide range of initiatives in the company and will strengthen and provide additional depth in our executive leadership equels reaffirms his strong commitment to the future of hemispherx stating under my leadership this company will be absolutely committed to the goals of stronger financial performance and a renewed commitment to creating shareholder value i say this not just because i believe in myself but primarily because of my strong and unwavering belief in the importance of our flagship experimental drug ampligenrintatolimod and our fda approved drug alferon as having great potential to play a significant role in the important and developing field of immunological therapy for a variety of diseases such as cancer and numerous acute and chronic viral infections this is the reason i have become a major stockholder over the years and the reason i am prepared to serve as president about hemispherx biopharma hemispherx biopharma inc is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders hemispherxs flagship products include alferon n injection® and the experimental therapeutics ampligen® and alferon® ldo ampligen® is an experimental rna nucleic acid being developed for globally important debilitating diseases and disorders of the immune system including chronic fatigue syndrome hemispherxs platform technology includes components for potential treatment of various severely debilitating and life threatening diseases because both ampligen® and alferon® ldo are experimental in nature they are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials hemispherx has patents comprising its core intellectual property estate and a fully commercialized product alferon n injection® approved for sale in the us and argentina the fda approval of alferon n injection® is limited to the treatment of refractory or recurrent external genital warts in patients  years of age or older the companys alferon n injection® approval in argentina includes the use of alferon n injection® under the brand name naturaferon for use in any patients who fail or become intolerant to recombinant interferon including patients with chronic active hepatitis c infection the company wholly owns and exclusively operates a gmp certified manufacturing facility in the united states for commercial products for more information please visit wwwhemispherxnet forwardlooking statements the foregoing release contains forwardlooking statements that can be identified by words such as will be investigative interim potential or similar terms or by express or implied discussions regarding potential efficacy for hemispherxs ampligen® or regarding potential future revenues from ampligen® you should not place undue reliance on these statements such forwardlooking statements are based on the current beliefs and expectations of management regarding future events and are subject to significant known and unknown risks and uncertainties should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect actual results may vary materially from those set forth in the forwardlooking statements there can be no guarantee that ampligen® will receive regulatory approval or be commercially successful in the future in particular managements expectations regarding ampligen® could be affected by among other things the uncertainties inherent in research and development including unexpected clinical trial results and additional analysis of existing clinical data unexpected regulatory actions or delays or government regulation generally the companys ability to obtain or maintain proprietary intellectual property protection general economic and industry conditions global trends toward health care cost containment including ongoing pricing pressures unexpected manufacturing issues and other risks and factors described in hemispherxs filings with the securities and exchange commission including the most recent reports on forms k q and k on file with the us securities and exchange commission hemispherx is providing the information in this press release as of this date and does not undertake any obligation to update any forwardlooking statements contained in this press release as a result of new information future events or otherwise disclosure notice the information in this press release includes certain forwardlooking statements including without limitation statements about additional steps which the fda may require and hemispherx may take in continuing to seek commercial approval of the ampligen® nda for the treatment of chronic fatigue syndrome in the united states the production of new alferon® api inventory will not commence until the capital improvement and validation phases are complete while the facility is approved by fda under the biological license application bla for alferon® this status will need to be reaffirmed upon the completion of the facilitys enhancements prior to commercial sale of newly produced inventory product if and when we obtain a reaffirmation of fda bla status and have begun production of new alferon® api we will need fda approval as to the quality and stability of the final product to allow commercial sales to resume the final results of these and other ongoing activities could vary materially from hemispherxs expectations and could adversely affect the chances for approval of the ampligen® nda in the united states and other countries any failure to satisfy the fda regulatory requirements or the requirements of other countries could significantly delay or preclude outright approval of the ampligen® nda in the united states and other countries information contained in this news release other than historical information should be considered forwardlooking and is subject to various risk factors and uncertainties including but not limited to general industry conditions and competition general economic factors the companys ability to adequately fund its projects the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally trends toward healthcare cost containment technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval the companys ability to accurately predict the future market conditions manufacturing difficulties or delays dependence on the effectiveness of the companys patents and other protections for products and the exposure to litigation including patent litigation andor regulatory actions as well as numerous other factors discussed in this release and in the companys filings with the securities and exchange commission the final results of these efforts could vary materially from hemispherxs expectations finally the projection of savings above is subject to change based upon operational requirements of the company and the possibility that additional finance and accounting staff may be required to accomplish the companys goals and objectives the photo is also available at newscom wwwnewscomcom and via ap photoexpress companyinvestor contact charles jones cjones  associates public relations office  cell  email cjonescjonesprcom related articles other press releases by hemispherx biopharma inc hemispherx updates status of immunooncology program in pancreatic cancer july    hemispherx biopharma repurposes ampligen in immunooncology may    hemispherx biopharma enhances ampligen manufacturing and scientific capabilities may    hemispherx biopharma announces financial results for the three months ended march   may    hemispherx biopharma announces financial results for the year ended december   march     other news releases in directors and officers in the last  days profile hemispherx biopharma inc   subscribe via rss  subscribe via atom  javascript philadelphia pennsylvania united states   httpwwwhemispherxnet contact data companyinvestor contact charles jones cjones  associates public relations office  cell  email cjonescjonesprcom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files thomas k equels jpeg   x  image url  copy the link below thomas k equels president of hemispherx biopharma formats available original large medium small hemispherx biopharma inc logo logo url  copy the link below formats available original medium small tags thomas k equels president hemispherx biopharma heb biotechnology pharmaceuticals management changes newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved thomas k equels profile  equels law firm  attorneys at law  florida litigation personal injury and family law equels law firm   ponce de leon blvd suite coral gables fl  more locations firm profile practice areas resources the attorneys contact us home page thomas k equels   tom equels is the president and managing director of the equels law firm his practice is devoted to complex litigation with particular emphasis on civil racketeering business torts and commercial matters for more than  years tom has represented national and state governments and companies in the banking insurance aviation pharmaceutical construction and development industries he has extensive experience in international matters and has served as counsel for the republic of panama and chinese national petroleum corp he has worked extensively in europe as well as in south america asia and africa mr equels currently serves as cfo general counsel and a director of the board of hemispherx biopharma inc nyse mktheb mr equels received his law degree with high honors from florida state university and is a graduate summa cum laude of troy state university   career achievements obtained a  million judgment in  on behalf of his client hemispherx biopharma inc amex heb against johannesburg consolidated investments jci and former jci officers rb kebble and hc buitendag the judgment entered august   marks the conclusion of the federal lawsuit first filed in late  against jci et al obtained a  million judgment in  in a breach of contract action against bear stearns for the delaware insurance commissioner related to an insolvent insurance company obtained a  million judgment in  against boy band guru lou pearlman of trans continental records inc obtained a  million judgment against manuel noriega for public money he misappropriated from the republic of panama recovered more than  million misappropriated and money laundered overseas by former insiders of a nowdefunct insurance company being liquidated by the state of delaware’s insurance commissioner obtained and collected a  million judgment against the fdic for breach of contract involving a client’s purchase of a national mortgage company owned by a failed savings and loan prosecuted a bank fraud claim against an international lender which resulted in a jury awarding  million damages for fraud and an order invalidating a  million mortgage obtained a jury verdict and recovered over  million in an eminent domain case in which the department of transportation was offering only    academic achievements received juris doctor with high honors florida state university college of law  member of the order of the coif received bachelor’s degree summa cum laude troy state university  received master’s degree in management troy state university    professional and community involvement honored with two distinguished flying crosses the bronze star  air medals  with “v” device and the purple heart for combat actions as a pilot during the vietnam war awarded the florida bar president’s pro bono service award  awarded the federal bar public service award  awarded the guild of catholic lawyers st thomas more award  received the southern christian leadership conference of miami’s dr martin luther king jr community service award  member florida bar member american bar association member academy of florida trial lawyers   references catherine mulholland deputy commissioner of insurance state of delaware retired  harlech drive wilmington delaware   kmulhollandcomcastnet   daniel a orth iii executive director illinois life  health insurance guaranty association  w bryn mawr avenue suite  chicago illinois   dorthilhigaorg   archbishop thomas g wenski the archdiocese of miami  biscayne blvd miami shores fl   comments are closed home firm profile practice areas the attorneys resources contact us  equels law firm all rights reserved equels thomas k  the wall street transcript thomas k equels thomas k equels ms jd was named chief executive officer in february  served as president since august  has been a director since  and presently serves as our executive vice chairman secretary and general counsel and litigation counsel of hemispherx biopharma inc mr equels previously served as chief financial officer from december  to february  also for over a quarter century mr equels has represented national and state governments as well as companies in the banking insurance aviation pharmaceutical and construction industries he has extensive experience in international business matters on numerous occasions mr equels has served as a courtappointed receiverchief executive for distressed businesses mr equels received his juris doctor degree with high honors from florida state university he is a summa cum laude graduate of troy university and also obtained his master of science degree from troy he is a member of the florida bar association and the american bar association related interviewsinterview with the ceo president executive vice chairman secretary general counsel and litigation counsel and the chairman hemispherx biopharma inc nysemkthebaugust   cartlatest newsall american usc footbal player joseph m boskovich jr now picks all american value stocks for his clientspaul hogan picks tech dividend growers microchip technology nasdaqmchp xilinx nasdaqxlnx and versum materials nysevsm gallons of water to produce a mcdonalds nysemcd quarter pounder how will investors profitthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsbuilding diversified portfolios with quality global equitiesgregory d padillaalberto jimenez crespo published july   in investing strategiescompanies covered amzn  aapl mu whr kimbera gs vod ppg shw viv pey buy building accountability and avoiding mistakes through the decision processdean pagonis published july   in investing strategiescompanies covered cmp sbh amzn ulta cvs lrlcy kmb www sdf buy finding optimal balance sheets by utilizing high yield market expertisezach miller published july   in investing strategiescompanies covered lsxmk siri bll chtr armk buy most popular reportsinvesting strategies published july  buy wireless communications  telecom published july  buy investing strategies published july  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsbuilding diversified portfolios with quality global equitiesbuilding accountability and avoiding mistakes through the decision processfinding optimal balance sheets by utilizing high yield market expertise analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google